September 18, 2020

The Niche

Knoepfler lab stem cell blog

Arnold Kriegstein

2 min read

When it comes to coverage of stem cell research in the media, science news can both be cool, but also surprising. Some of the more interesting publications don’t always draw news coverage too. This post is a list of recent notable pubs and news. First some pubs. How good are human brain organoids at modeling human brain development? A new meeting abstract from the Arnold Kriegstein lab (covered here at The Scientist) claims not so good. The abstract concludes, ” Although organoids are a …Read More

6 min read

Stem cells for autism? After watching this area for many years, I’m not sure there’s any “there there”. There are logical reasons to think that certain stem cells might help many specific diseases, but in my view autism isn’t likely to be one of them. I hope I’m wrong, but today at least in 2018, it’s not looking promising. To be clear, I’m not talking about indirectly using stem cells for non-clinical trial research to provide conceptual and translational insights into autism spectrum disorder, …Read More

2 min read

What’s the scoop on stem cells for autism? Could stem cells make a real difference for autism patients and their families? CNN has a big, high-profile new article out today on the Duke stem cell trial for autism that has been ongoing for a while and I’m wondering how good a job CNN did on this one. Too often media over-hype stem cells and this includes for autism. I’ve covered the Duke trial before here and here, which is run by Dr. Joanne Kurtzberg, a scholar in …Read More

5 min read

By Jeanne Loring As the California Institute for Regenerative Medicine (CIRM) celebrates its successes on its 10th anniversary, there is coincidentally a less happy CIRM-related event. One of CIRM’s first investments in stem cell research was a network of dedicated stem cell laboratories throughout California. This program, called “shared labs” has been cancelled. The shared lab idea originated as a means for California researchers to work on human embryonic stem cells without compromising their funding from the NIH. CIRM invested a million dollars for …Read More